Womens Imaging: Page 64

Ultrasound molecular imaging can characterize ovarian masses
By Amerigo Allegretto
Wednesday, November 30 | 1:30 p.m.-2:30 p.m. | W6-SSOB02-6 | E353CUltrasound molecular imaging (USMI) using a clinical-grade contrast agent shows promise for characterizing ovarian masses, according to this scientific presentation.
November 20, 2022
Ultrasound is cost-effective in evaluating recalled breast lesions
By Amerigo Allegretto
Tuesday, November 29 | 3:00 p.m.-4:00 p.m. | T7-SSBR07-5 | E450BIn this presentation, research will show how using ultrasound first to assess noncalcified lesions recalled by digital breast tomosynthesis (DBT) is cost-effective and can improve patient quality of life.
November 20, 2022
Screening breast imaging findings differ between Black and white women
By Amerigo Allegretto
Screen-detected breast cancer in Black women is less likely to appear as architectural distortion and more likely to present with calcifications compared with white women, a team from Washington University in St. Louis has reported.
November 17, 2022
2019 01 23 20 13 5254 Patient African American Woman 400
Ultrasound guidance effective in DCIS surgery
By Amerigo Allegretto
Ultrasound-guided surgery in women with ductal carcinoma in situ (DCIS) is effective and eliminates the need for a guide wire, suggests research presented November 15 at the 13th European Breast Cancer Conference in Barcelona.
November 16, 2022
2021 12 21 00 21 1462 Patient Breast Ultrasound 400
Breast MRI access grows among women covered by Medicare
By Amerigo Allegretto
Sunday, November 27 | 2:30 p.m.-3:30 p.m. | S5-SSBR02-5 | Room E450BWomen with Medicare insurance have seen increased access to breast MRI exams over the past decade, especially in outpatient hospital settings, according to this presentation.
November 16, 2022
Lunit secures Insight MMG validation deal in Australia
By AuntMinnie.com staff writers
Lunit has signed a contract for a validation trial of its Insight MMG software to be used in Australia's breast cancer screening program.
November 15, 2022
2020 03 04 21 21 6197 Artificial Intelligence Ai Hand 400 20200304215813
Quality improvements lead to rebounding cancer screening numbers
By Amerigo Allegretto
Implementing quality improvement interventions as part of a national collaborative led to rebound volumes in cancer screening, according to findings published November 16 in JAMA Network Open.
November 15, 2022
2020 07 28 22 54 1763 Breast Mammography Tech 400
Road to RSNA 2022: Women's Imaging Preview
By Amerigo Allegretto
At RSNA 2022, attendees will have the opportunity to take in new research and innovations in women's imaging, including sessions that highlight the increasing role of supplemental imaging modalities such as ultrasound and MRI, the growing power of artificial intelligence (AI), the continued rise of digital breast tomosynthesis in breast imaging practices, and more.
November 14, 2022
Which radiotracer is best for preoperative lymph node assessment?
By Amerigo Allegretto
Wednesday, November 30 | 3:00 p.m.-4:00 p.m. | W7-SSBR09-2 | Room E451BIn this scientific talk, researchers will compare the performance of F-18 FDG and F-18 fluoroethylcholine in preoperative lymph node assessment of breast cancer patients on PET/MRI.
November 14, 2022
DCE-MRI predicts pathologic response in breast cancer treatment
By Amerigo Allegretto
Wednesday, November 30 | 3:00 p.m.-4:00 p.m. | W7-SSBR09-3 | Room E451BIn this talk, researchers will demonstrate how initial ultrafast dynamic contrast-enhanced MRI (DCE-MRI) can aid in predicting complete pathologic response in breast cancer patients.
November 14, 2022
Can DBT serve as a safety net in breast cancer screening?
By Amerigo Allegretto
Wednesday, November 30 | 9:30 a.m.-10:30 a.m. | W3-SSBR08-6 | Room E451BThe utility of digital breast tomosynthesis (DBT) as a "safety net" in breast cancer screening will be discussed in this presentation, including its impact on cancer outcomes.
November 14, 2022
Deductible payments discourage breast imaging for women
By Amerigo Allegretto
Tuesday, November 29 | 3:00 p.m.-4:00 p.m. | T7-SSBR06-3 | Room E451BIn this session, a study will highlight how high-deductible health insurance plans discourage over one in five women from returning for diagnostic workup, as well as nearly the same number of women to skip screening altogether.
November 14, 2022
Previous Page
Page 64 of 701
Next Page